Article Information
History
- September 30, 2021.
Article Versions
- Version 1 (September 22, 2021 - 06:55).
- Version 2 (September 22, 2021 - 23:55).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- 1Argonne National Laboratory, 9700 South Cass Avenue, Lemont, IL 60439, USA
- 2The University of Chicago, 5801 S Ellis Ave, Chicago, IL 60637
- 3Schar School of Policy and Government, George Mason University, 3351 Fairfax Drive MS 3B1 George Mason University Arlington VA. 22201
- ↵*Corresponding Author; E-mail: cgraziani{at}anl.gov
Posted September 30, 2021.
The Delta Variant Had Negligible Impact on COVID-19 Vaccine Effectiveness in the USA
